title: Preparation of mucoadhesive oral patches containing tetracycline hydrochloride and carvacrol for treatment of local mouth bacterial infections and candidiasis.
abstract: The specific aim of this work was to prepare mucoadhesive patches containing tetracycline hydrochloride and carvacrol in an attempt to develop a novel oral drug delivery system for the treatment of mouth infections. The bilayered patches were prepared using ethyl cellulose as a backing layer and carbopol 934 as a matrix mucoadhesive layer. Patches were prepared with different loading amounts of tetracycline hydrochloride and carvacrol. The antimicrobial activity was assessed for the prepared patches using the disc-diffusion method against the yeast Candida albicans and five bacterial strains, including Pseudomonas aeruginosa, Escherichia coli, Bacillus cereus, Staphylococcus aureus, and Bacillus bronchispti. In this work, we highlighted the possibility of occurrence of a synergistic action between carvacrol and tetracycline. The best formulation was selected based on microbiological tests, drug release, ex-vivo mucoadhesive performance, and swelling index. Physical characteristics of the selected formulations were determined. These included pH, patch thickness, weight uniformity, content uniformity, folding endurance, and patch stability.
authors: Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan. obeidatrana@yahoo.com
authors: Rana M
authors: RM
authors: Obaidat
authors: Ammar
authors: A
authors: Bader
authors: Wafa
authors: W
authors: Al-Rajab
authors: Ghassan
authors: G
authors: Abu Sheikha
authors: Aiman A
authors: AA
authors: Obaidat
references: J Clin Periodontol. 1995 Jan;22(1):22-35
references: 7706536
references: Drug Discov Today. 2008 Mar;13(5-6):247-53
references: 18342801
references: J Microencapsul. 1997 Mar-Apr;14(2):175-87
references: 9132469
references: J Periodontol. 1983 Oct;54(10):575-9
references: 6580409
references: Arch Pharm Res. 2007 Mar;30(3):381-6
references: 17424947
references: Int J Pharm. 2005 Apr 27;294(1-2):217-32
references: 15814246
references: J Am Dent Assoc. 2000 Feb;131(2):184-95
references: 10680386
references: Drug Dev Ind Pharm. 2007 Aug;33(8):855-64
references: 17729103
references: J Control Release. 2004 Mar 24;95(3):521-33
references: 15023463
references: AAPS PharmSciTech. 2007 Sep 14;8(3):E75
references: 17915825
references: Biomaterials. 2004 Aug;25(17):3743-50
references: 15020150
references: BMC Microbiol. 2005 Jun 17;5:36
references: 15963233
references: Int J Pharm. 2003 Jun 18;259(1-2):47-55
references: 12787635
references: Pak J Pharm Sci. 2008 Jul;21(3):241-8
references: 18614419
references: Acta Derm Venereol. 2001 Jun-Jul;81(3):178-80
references: 11558872
references: Drug Dev Ind Pharm. 2007 Apr;33(4):437-48
references: 17523008
references: J Pharm Sci. 2004 Dec;93(12):2927-35
references: 15459950
references: AAPS PharmSciTech. 2007 Jun 22;8(2):Article 45
references: 17622120
references: Curr Drug Deliv. 2004 Jan;1(1):17-25
references: 16305367
references: J Pharm Pharm Sci. 1999 May-Aug;2(2):53-61
references: 10952770
references: J Pharm Sci. 1983 Oct;72(10):1189-91
references: 6644570
references: Oral Microbiol Immunol. 1992 Apr;7(2):113-7
references: 1528631
references: AAPS PharmSciTech. 2006 Sep 15;7(3):76
references: 17025256
references: Eur J Pharm Biopharm. 2000 Jul;50(1):83-99
references: 10840194